Regenxbio Inc
RGNX
Market Cap$464.99M
Close$
$25.02
188.9% upside
Current Fair Value
188.9% upsideUndervalued by 188.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $464.99 Million |
|---|---|
| Enterprise Value | $447.36 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.59 |
| Beta | 1.09 |
| Outstanding Shares | 51,362,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.02 |
|---|---|
| PEG | 2.75 |
| Price to Sales | 2.89 |
| Price to Book Ratio | 1.73 |
| Enterprise Value to Revenue | 2.85 |
| Enterprise Value to EBIT | -3.03 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Regenxbio Inc
CEO: Kenneth Mills